1270324-45-2 Usage
Uses
Used in Pharmaceutical Industry:
(2S)-2-amino-3-(5-bromo-2-chlorophenyl)propanoic acid is used as a potential antipsychotic agent for the treatment of psychiatric disorders such as schizophrenia. It modulates the activity of serotonin and dopamine receptors in the brain, which are implicated in the pathophysiology of these disorders.
Used in Neurology:
(2S)-2-amino-3-(5-bromo-2-chlorophenyl)propanoic acid is used as a potential therapeutic agent for the treatment of neurological conditions. Its ability to modulate neurotransmitter receptors suggests that it may have potential in managing symptoms associated with various neurological disorders.
Used in Pain Management:
(2S)-2-amino-3-(5-bromo-2-chlorophenyl)propanoic acid is used as an analgesic agent due to its potential anti-inflammatory and pain-relieving properties. It may be useful in the management of chronic pain conditions and inflammatory disorders.
Used in Research:
(2S)-2-amino-3-(5-bromo-2-chlorophenyl)propanoic acid is used as a research tool in the study of neurotransmitter receptor activity and the development of novel therapeutic agents for psychiatric and neurological disorders. Its unique chemical structure and pharmacological properties make it a valuable compound for investigating the mechanisms underlying these conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 1270324-45-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,7,0,3,2 and 4 respectively; the second part has 2 digits, 4 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1270324-45:
(9*1)+(8*2)+(7*7)+(6*0)+(5*3)+(4*2)+(3*4)+(2*4)+(1*5)=122
122 % 10 = 2
So 1270324-45-2 is a valid CAS Registry Number.
1270324-45-2Relevant academic research and scientific papers
SMALL MOLECULE MODULATORS OF IL-17
-
Page/Page column 73, (2020/09/30)
The present invention relates to a compound according to formula I and pharmaceutically acceptable salts, hydrates, or solvates thereof. The invention further relates to, to said compounds for use in therapy, to pharmaceutical compositions comprising said
